As no studies have been published comparing the effects of irbesartan, amlodipine and standard blood pressure control in ESRD patients, we conservatively assumed that when a patient developed ESRD ...

We randomly assigned 1715 hypertensive patients with nephropathy due to type 2 diabetes to treatment with irbesartan (300 mg daily), amlodipine (10 mg daily), or placebo. The target blood pressure ...

To investigate the synergism of low-doses of amlodipine and irbesartan on reduction of blood pressure variability (BPV), amelioration of baroreflex sensitivity (BRS) and organ protection in ...

Lewis et al. [67] studied 1,715 hypertensive patients with nephropathy given irbesartan, amlodipine, or placebo. Mean duration of follow-up was 2.6 years. Treatment with irbesartan (300 mg ...

took a single capsule containing four blood pressure-lowering drugs—irbesartan, amlodipine, hydrochlorothiazide, and atenolol—at quarter doses for 4 weeks. All of the 18 patients taking the ...

Several pharmaceutical companies have announced recalls of versions of valsartan, irbesartan and losartan ... tables that contain the drugs amlodipine and valsartan and another combo drug ...

Irbesartan in combination with amlodipine plus hydrochlorothiazide is used to control high blood pressure, the release states. This recall is the latest in the past few months. Since July ...

A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent ...